Roche - Neulastim DM

Roche have a drug (called G-CSF) that can improve the survival rates of cancer patients receiving chemotherapy.

Roche – Neulastim DM

Category: Single Channel Focus CampaignAgency: Insight NZAdvertiser: Roche

SUMMARY

Roche have a drug (called G-CSF) that can improve the survival rates of cancer patients receiving chemotherapy.

Unfortunately, while it is available in New Zealand many of our cancer specialists do not use it, or they use it in some cases and not others.

However, traditional methods of communication were not working, and doctors were not listening. We had a very important job to do.

MARKETING CHALLENGE

If you have cancer chances are you'll get chemotherapy. You typically receive it in cycles...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands